---
figid: PMC5770599__onc2017313f2
figtitle: Regulation of Wnt/Beta-catenin signaling and oncogenic NFKB pathway by ubiquitylating
  enzymes in CRC
organisms:
- Danio rerio
- Xenopus laevis
- Argyrosomus regius
- Homo sapiens
- Mus musculus
- Lareunionomyces loeiensis
- Ovis aries
organisms_ner:
- Homo sapiens
- Ovis aries
- Mus musculus
- Danio rerio
- Xenopus laevis
pmcid: PMC5770599
filename: onc2017313f2.jpg
figlink: /pmc/articles/PMC5770599/figure/fig2/
number: F2
caption: Regulation of Wnt/β-catenin signaling and oncogenic NF-κB pathway by ubiquitylating
  enzymes in CRC. Transmembrane E3 ligases RNF43 and ZNRF3 utilize disheveled segment
  polarity protein (DVL) as an adaptor to induce the endocytosis of Frizzled–LRP5/6
  complex and abrogation of Wnt signaling. Binding of Wnt proteins to Wnt receptors
  results in the inactivation of GSK3β. β-catenin remains unphosphorylated, and it
  translocates to the nucleus where it binds to the LEF/TCF transcription complex,
  activating Wnt/β-catenin downstream target gene transcription. In the absence of
  Wnt, the scaffolding protein AXIN assembles a multiprotein destruction complex that
  consists of β-catenin, APC and GSK3β. β-catenin is phosphorylated by GSK3β and recognized
  by SCF-β-TrCP, leading to ubiquitylation and degradation of β-catenin. XIAP induces
  monoubiquitylation of TLE and releases TLE from the TCF/LEF complex, thereby initiating
  a canonical Wnt transcriptional program in CRC. K63-linked ubiquitylation of TRAF6
  leads to the recruitment of the IKK (IκB kinase) complex (α, β, γ) and activation
  of IKK through TRAF6-mediated polyubiquitination. Activation of IKK kinase complex
  results in SCF-β-TrCP-mediated ubiquitination and proteasomal degradation of IκB
  (inhibitor of NF-κB kinase), thereby enabling the translocation of p50 and p65 to
  the nucleus and induction of NF-κB target genes, leading to positive regulation
  of NF-κB signaling. FBW7 preferentially targets phosphorylated JUN both by GSK3β
  or JNK and promotes JUN degradation in the proteasome. Accordingly, FBW7 depletion
  results in accumulation of phosphorylated JUN and stimulation of AP-1 activity.
  AP-1, activator protein 1; AXIN, axis inhibition protein; DVL, disheveled segment
  polarity protein; FBW7, F-box and WD repeat domain-containing 7; GSK3β, glycogen
  synthase kinase-3 beta; JUN, AP-1 transcription factor subunit; LEF/TCF, lymphoid
  enhancer factor/T-cell factor; LRP5/6, low-density lipoprotein receptor-related
  protein 5/6; TRAF6, tumor necrosis factor receptor-associated factor; XIAP, X-chromosome-linked
  inhibitor of apoptotic proteins.
papertitle: Functional significance and therapeutic implication of ring-type E3 ligases
  in colorectal cancer.
reftext: L Liu, et al. Oncogene. 2018 Jan 11;37(2):148-159.
year: '2018'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9647957
figid_alias: PMC5770599__F2
figtype: Figure
redirect_from: /figures/PMC5770599__F2
ndex: 6f6771dc-ded2-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5770599__onc2017313f2.html
  '@type': Dataset
  description: Regulation of Wnt/β-catenin signaling and oncogenic NF-κB pathway by
    ubiquitylating enzymes in CRC. Transmembrane E3 ligases RNF43 and ZNRF3 utilize
    disheveled segment polarity protein (DVL) as an adaptor to induce the endocytosis
    of Frizzled–LRP5/6 complex and abrogation of Wnt signaling. Binding of Wnt proteins
    to Wnt receptors results in the inactivation of GSK3β. β-catenin remains unphosphorylated,
    and it translocates to the nucleus where it binds to the LEF/TCF transcription
    complex, activating Wnt/β-catenin downstream target gene transcription. In the
    absence of Wnt, the scaffolding protein AXIN assembles a multiprotein destruction
    complex that consists of β-catenin, APC and GSK3β. β-catenin is phosphorylated
    by GSK3β and recognized by SCF-β-TrCP, leading to ubiquitylation and degradation
    of β-catenin. XIAP induces monoubiquitylation of TLE and releases TLE from the
    TCF/LEF complex, thereby initiating a canonical Wnt transcriptional program in
    CRC. K63-linked ubiquitylation of TRAF6 leads to the recruitment of the IKK (IκB
    kinase) complex (α, β, γ) and activation of IKK through TRAF6-mediated polyubiquitination.
    Activation of IKK kinase complex results in SCF-β-TrCP-mediated ubiquitination
    and proteasomal degradation of IκB (inhibitor of NF-κB kinase), thereby enabling
    the translocation of p50 and p65 to the nucleus and induction of NF-κB target
    genes, leading to positive regulation of NF-κB signaling. FBW7 preferentially
    targets phosphorylated JUN both by GSK3β or JNK and promotes JUN degradation in
    the proteasome. Accordingly, FBW7 depletion results in accumulation of phosphorylated
    JUN and stimulation of AP-1 activity. AP-1, activator protein 1; AXIN, axis inhibition
    protein; DVL, disheveled segment polarity protein; FBW7, F-box and WD repeat domain-containing
    7; GSK3β, glycogen synthase kinase-3 beta; JUN, AP-1 transcription factor subunit;
    LEF/TCF, lymphoid enhancer factor/T-cell factor; LRP5/6, low-density lipoprotein
    receptor-related protein 5/6; TRAF6, tumor necrosis factor receptor-associated
    factor; XIAP, X-chromosome-linked inhibitor of apoptotic proteins.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - ZNRF3
  - RNF43
  - LRP6
  - LRP5
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - APC
  - PROC
  - AXIN1
  - AXIN2
  - KITLG
  - CTNNB1
  - PSMA1
  - PSMA2
  - PSMA3
  - PSMA4
  - PSMA5
  - PSMA6
  - PSMA7
  - PSMA8
  - PSMB1
  - PSMB10
  - PSMB2
  - PSMB3
  - PSMB4
  - PSMB5
  - PSMB6
  - PSMB7
  - PSMB8
  - PSMB9
  - PSMC1
  - PSMC2
  - PSMC3
  - PSMC4
  - PSMC5
  - PSMC6
  - PSMD1
  - PSMD10
  - PSMD11
  - PSMD12
  - PSMD13
  - PSMD14
  - PSMD2
  - PSMD3
  - PSMD4
  - PSMD5
  - PSMD6
  - PSMD7
  - PSMD8
  - PSMD9
  - PSME1
  - PSME2
  - PSME3
  - PSMF1
  - SEM1
  - USP5
  - BTRC
  - TRAF6
  - IKBKG
  - JUN
  - JUNB
  - JUND
  - FBXW7
  - GSK3B
  - CD40
  - ARHGEF7
  - ASCC1
  - H3P40
  - RELA
  - SYT1
  - GORASP1
  - WNK1
  - XIAP
  - TLE1
  - TLE2
  - TLE3
  - TLE4
  - TLE5
  - TLE6
  - TLE7
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - MYC
  - NFKB1
  - IL6
  - TNF
  - IL1B
  - NFKB2
  - Znrf3
  - Rnf43
  - Lrp6
  - Lrp5
  - Dvl1
  - Apc
  - Axin1
  - Kitl
  - Ctnnb1
  - Btrc
  - Traf6
  - Jun
  - Fbxw7
  - Gsk3b
  - Nfkbib
  - Cdc37
  - Lsp1
  - Nfkb1
  - Pold2
  - Cd40
  - Dctn2
  - Rela
  - Gorasp1
  - Xiap
  - Il6
  - Tnf
  - Il1
  - znrf3
  - rnf43
  - lrp6
  - lrp5
  - apc
  - ctnnb1
  - traf6
  - jun
  - gsk3ba
  - nfkb1
  - rela
  - xiap
  - myca
  - tnfrsfa
  - tnfb
  - znrf3.S
  - lrp6.L
  - lrp6.S
  - lrp5.L
  - dvl2.L
  - dvl2.S
  - apc.L
  - axin1.S
  - ctnnb1.S
  - ctnnb1.L
  - btrc.S
  - btrc.L
  - traf6.L
  - jun.S
  - jun.L
  - gsk3b.L
  - gsk3b.S
  - arhgef7.S
  - arhgef7.L
  - rela.L
  - rela.S
  - xiap.L
  - ccnd1.S
  - ccnd1.L
  - myc.S
  - myc.L
  - nfkb1.L
  - nfkb1.S
  - il6.L
  - il6.S
  - tnf.L
  - il1b.S
  - il1b.L
  - Cancer
---
